Smith & Nephew plc Hits New 1-Year High at $89.49 (SNN)
Smith & Nephew plc (NYSE:SNN) shares reached a new 52-week high on Wednesday , Analyst Ratings.Net reports. The company traded as high as $89.49 and last traded at $89.19, with a volume of 127,827 shares changing hands. The stock had previously closed at $86.77.
A number of research firms have recently commented on SNN. Analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Monday. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Smith & Nephew plc in a research note on Thursday, May 29th. Finally, analysts at Investec downgraded shares of Smith & Nephew plc from a “buy” rating to a “hold” rating in a research note on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. Smith & Nephew plc has a consensus rating of “Hold” and an average target price of $82.50.
The stock has a 50-day moving average of $78.49 and a 200-day moving average of $74.75. The company has a market cap of $17.155 billion and a price-to-earnings ratio of 27.81.
Smith & Nephew plc (NYSE:SNN) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.89 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.93 by $0.04. On average, analysts predict that Smith & Nephew plc will post $4.13 earnings per share for the current fiscal year.
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.